This document discusses the use of Mepilex-Ag dressings for burn wounds. It provides 3 case studies of patients who were treated with Mepilex-Ag dressings after sustaining burns. The dressings were found to provide powerful antimicrobial action, improve wound healing with no staining or tissue damage, minimize pain at dressing changes due to their gentle adhesive layer, and maintain flexibility to avoid restricting range of motion. Overall, the case studies demonstrated the benefits of Mepilex-Ag dressings for managing burn wounds.
The Ultimate Guide to Foam Dressings for Wound Care.pptxWound Care
Discover everything you need to know about foam dressings for wound care in our comprehensive guide. From their unique properties to their applications and benefits, this guide will equip you with the knowledge to make informed decisions about foam dressings for optimal wound healing.
The Ultimate Guide to Foam Dressings for Wound Care.pptxWound Care
Discover everything you need to know about foam dressings for wound care in our comprehensive guide. From their unique properties to their applications and benefits, this guide will equip you with the knowledge to make informed decisions about foam dressings for optimal wound healing.
DermaWound makes 'complicated' woundcare easier than ever.
DermaWound works 65-90% more rapidly and efficiently than any other standard or alternative products including: expensive growth-hormone based salves; vacuum systems; electrical stimulators; hyperbaric oxygen chambers; grafts; hydrogels; zinc oxide, silver, carbon or honey products; etc., and will go head to head with any competition, any place, any time to prove it.
This is simply the best product there is.
Triage Meditech is one of the leading Indian medical technology companies acquired a respectable position in Advanced Wound Care arena. We are the leading manufacturers and suppliers of Negative Pressure Wound Therapy (NPWT) products in Indian subcontinent. We have further enhanced our portfolio with Advance Wound Dressings, Colostomy Products, Solutions for Venous Insufficiency, and Surgical Disposables and Consumables. Our R&D team is dedicated to continuous advancement in offerings to create effective products at an affordable cost and helping healthcare professionals and caregivers to offer best practice solutions to their patients. Triage Meditech is an ISO 9001:2008, 13485:2003 certified and DCGI regulated company. We follow WHO Good Manufacturing Practice (GMP) and our products are CE Certified. We have Pan India presence through direct and dealers network and currently we export our products to more than 11 countries.
Our new programmable CCNPWT system delivers controlled negative pressure in the wound site to accelerate healing process. The system delivers continuous, variable and intermittent therapy settings for effective therapy goals. The fully loaded system with safety parameters for leakage, blockage, canister full and system inactive conditions. The robust system has been designed light just about 950gms for mobile patients with a very user friendly operation menu.
CLOSED CYCLIC NEGATIVE PRESSURE WOUND THERAPY (CCNPWT), the flexible PU foam dressing adapts to the contours of deep & irregular surface of the wound bed on application of Negative Pressure Therapy. The Specially designed antimicrobial, hydrophobic, non-linear networked foam dressing removes bacteria colonised wound exudates, enhances dermal perfusion and simultaneously helps promote wound closure by primary or secondary intentions. The CCNPWT acti-foam dressing aggressively promotes uniform healthy granulation tissue formation throughout the wound bed.
If you’re looking to enhance your beauty routine or explore new ways to achieve your desired aesthetic results, then you’ve come to the right place. We’ll cover everything you need to know about aesthetic cannulas, from what they are to how to choose the right one for your procedure.
The Ultimate Guide to Foam Dressings for Wound Care.pptxWound Care
Discover everything you need to know about foam dressings for wound care in our comprehensive guide. From their unique properties to their applications and benefits, this guide will equip you with the knowledge to make informed decisions about foam dressings for optimal wound healing.
The Ultimate Guide to Foam Dressings for Wound Care.pptxWound Care
Discover everything you need to know about foam dressings for wound care in our comprehensive guide. From their unique properties to their applications and benefits, this guide will equip you with the knowledge to make informed decisions about foam dressings for optimal wound healing.
DermaWound makes 'complicated' woundcare easier than ever.
DermaWound works 65-90% more rapidly and efficiently than any other standard or alternative products including: expensive growth-hormone based salves; vacuum systems; electrical stimulators; hyperbaric oxygen chambers; grafts; hydrogels; zinc oxide, silver, carbon or honey products; etc., and will go head to head with any competition, any place, any time to prove it.
This is simply the best product there is.
Triage Meditech is one of the leading Indian medical technology companies acquired a respectable position in Advanced Wound Care arena. We are the leading manufacturers and suppliers of Negative Pressure Wound Therapy (NPWT) products in Indian subcontinent. We have further enhanced our portfolio with Advance Wound Dressings, Colostomy Products, Solutions for Venous Insufficiency, and Surgical Disposables and Consumables. Our R&D team is dedicated to continuous advancement in offerings to create effective products at an affordable cost and helping healthcare professionals and caregivers to offer best practice solutions to their patients. Triage Meditech is an ISO 9001:2008, 13485:2003 certified and DCGI regulated company. We follow WHO Good Manufacturing Practice (GMP) and our products are CE Certified. We have Pan India presence through direct and dealers network and currently we export our products to more than 11 countries.
Our new programmable CCNPWT system delivers controlled negative pressure in the wound site to accelerate healing process. The system delivers continuous, variable and intermittent therapy settings for effective therapy goals. The fully loaded system with safety parameters for leakage, blockage, canister full and system inactive conditions. The robust system has been designed light just about 950gms for mobile patients with a very user friendly operation menu.
CLOSED CYCLIC NEGATIVE PRESSURE WOUND THERAPY (CCNPWT), the flexible PU foam dressing adapts to the contours of deep & irregular surface of the wound bed on application of Negative Pressure Therapy. The Specially designed antimicrobial, hydrophobic, non-linear networked foam dressing removes bacteria colonised wound exudates, enhances dermal perfusion and simultaneously helps promote wound closure by primary or secondary intentions. The CCNPWT acti-foam dressing aggressively promotes uniform healthy granulation tissue formation throughout the wound bed.
If you’re looking to enhance your beauty routine or explore new ways to achieve your desired aesthetic results, then you’ve come to the right place. We’ll cover everything you need to know about aesthetic cannulas, from what they are to how to choose the right one for your procedure.
Similar to Mepilex ag by Dr. Sunil Keswani, National Burns Centre, Airoli (20)
Burns prevention program in Mumbai by Dr. Sunil Keswani, National Burns Centr...NationalBurnsCentre2000
Burns is a major problem in India. The treatment of Burns is extremely expensive. The outcome is uncertain inspite of best of treatment. Hence Prevention of Burns is much easier than treatment of Burns
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Mepilex ag by Dr. Sunil Keswani, National Burns Centre, Airoli
1. The use of Mepilex-Ag in BURNS
Dr Sunil Keswani
National Burns Centre,
Airoli, Navi Mumbai.
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
2. The problem
• All wounds are contaminated.
• One reason for impaired
healing
• Infected wounds are
more painful*
*Delphi round 1
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
Wound Care Division
3. ”Patients with a wound infection
generally suffer from more pain than those with
non-infected wounds.”
85%
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
Wound Care Division
4. Identifying the problem
Subtle signs of
infection some
odour, pain or
exudate
Healing progressing
normally
Increasing signs
- increasing odour
pain and/ or
exudate
Healing no longer
progressing
normally
Overt signs of local
infection; pus,
swelling, erythema
odour, pain, local
warmth
Surrounding tissue
involvement
Overt signs of local
and systemic
infection; pyrexia,
raised blood cell
count
Ref: EWMA position document : Management of wound infection. London: MEP Ltd,2006
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
5. Managing the problem
Subtle signs of
infection some
odour, pain or
exudate
Healing progressing
normally
Standard care
review and assess
Increasing signs
- increasing odour
pain and/ or
exudate
Healing no longer
progressing
normally
Start local
antimicrobial for 14
days then reassess
Overt signs of local
infection; pus,
swelling, erythema
odour, pain, local
warmth
Surrounding tissue
involvement
Overt signs of local
and systemic
infection; pyrexia,
raised blood cell
count
Systemic antibiotics
and
possibly local AM
Systemic antibiotics
and
possibly local AM
Ref: EWMA position document : Management of wound infection. London: MEP Ltd,2006
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
Wound Care Division
6. When to use anti-microbial
dressings?
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
Wound Care Division
7. Why would you use a
dressing with Safetac®?
• Safetac prevents pain and trauma
- hurts less at dressing changes and
during wear
- prevents maceration
• Absorption and retention
• With or without border
• Reliable antimicrobial action
- onset within 30 minutes
- effect for 7 days
- broad effect; MRSA, VRE
85%
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
8. Safetac technology – how it works
Safetac adhesive
technology
Traditional adhesives
The Safetac layer is extremely soft
and moulds to the uneven surface of the skin to
create a large effective contact area. On dressing
removal, Safetac distributes the peel force over a
large area of the skin under the dressing. The benefit
of this is that skin stripping is minimized, the skin
barrier preserved and pain minimized at removal.
Traditional adhesives are relatively inflexible and only
make contact with few points on the top of the skin.
Traditional adhesives therefore require an aggressive
adhesion in order to stay in place.
On removal the skin cells at the contact points will be
stripped and the skin barrier compromised. This will cause
pain.
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
9. Non-adherent to moist wound bed
• Less painful dressing removal
• Minimised risk of wound disturbance
• Easier dressing changes for clinicians
Leaves no residues
• Easier to clean the wound and
surrounding skin.
• No residues left in the wound
Will adhere gently to dry skin
• Protects the surrounding skin from
maceration
• No skin prep needed to protect the skin
Non-sensitizing
• No skin allergies
• Potentially longer wear time
No stripping of epidermal cells
• Less painful dressing removal
• Less damage to surrounding skin
Can be repositioned
• Easy to dress wounds, saves time
• Less waste, cost effective
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
10. Flexible, effective and less painful
Mepilex® Ag
4 sizes for chronic and
acute wounds
2 sizes for heel wounds
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
11. Safetac® layer
Less pain and trauma
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
12. Unique patented silver foam absorption
and antimicrobial action
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
14. Areas of use
Low to moderate exuding wounds
where an antimicrobial effect is
wanted.
Leg and foot ulcers, pressure
ulcers, partial thickness burns
- also for prevention.
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
15. Wound examples
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
16. How to use
Debride and cleanse the wound
according to local protocol
Choose a dressing where the
wound pad exceeds the wound
margins with at least 2 cm
Change according to wound
status; exudation, level of
contamination etc.
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
17. What Mepilex® Ag offers
Less pain for the patient will increase
quality of life and most probably also
be beneficial for the wound healing
Soft and conformable for highest
comfort and full range of motion
Substantial and significant
benefits in cost
effectiveness in the
treatment of partial
thickness burns*
*Puma 415
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
18. Burn Case Studies
Burn
Case
Study 1
CASE 1 – Arm Burn
36 HRS POST-BURN
Previously treated with Silver
Sulfadiazine
Application of Mepilex Ag
Antimicrobial soft silicone foam
dressing
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
19. Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
20. Case Study 1 – Day 1
CASE 1 – Arm Burn
36 HRS POST-BURN
Previously treated with Silver
Sulfadiazine
Application of Mepilex Ag
Antimicrobial soft silicone foam
dressing
21. Case Study 1 – Day 1
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
22. Case Study 1 – Day 1
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
23. Case Study 1 - Day 5
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
24. Case Study 1 - Day 5
Range of Motion
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
25. No staining & no tissue damage
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
Case Study 1 - Day 5
26. Case Study 1 - Day 5
Application of the dressings
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
27. Secondary dressings
Case Study 1 - Day 5
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
28. Removal of Mepilex Ag
Case Study 1 - Day 9
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
29. Removal of Mepilex Ag
Case Study 1 - Day 9
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
30. Removal of Mepilex Ag
Case Study 1 - Day 9
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
31. Removal of Mepilex Ag
Case Study 1 - Day 9
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
32. Case Study 1 - Conclusion
Powerful Antimicrobial Action
• Absence of Wound Bed Staining
• Reduces bacterial colonization
• Begins to inactivate common
wound pathogens within 30 min.
• Kills a broad range of pathogens,
including MRSA
• Sustained antimicrobial effect
for up to 7 days
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
34. Case Study 2 - Day 1
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
35. Case Study 2 - Day 1
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
36. Case Study 2 - Day 1
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
37. Case Study 2 - Day 6
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
38. Case Study 2 - Day 6
Improved comfort for the patient
• Maintains it’s flexible nature
• Does not inhibit range of motion
exercising
• Conforms easily to body contours
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
39. Case Study 3
Burn
Case
Study 3
Hot Soup Burn
Initial Consult Post Burn Day 3
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
40. Case Study 3 – Hot soup burn
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
41. Case Study 3 – Hot soup burn
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
42. Case Study 3 – Day 9
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
43. Case Study 3 – Day 9
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
44. Case Study 3 – Day 9
Minimizes trauma and pain at
dressing application and removal
• Gentle Removal
• Eliminates stripping of epidermal
cells
Dr. Sunil Keswani, National Burns Centre,
www.burns-india.com,
nbcairoli@gmail.com
New unique product- with important benefits – Safetac benefits, absorption, retention and a less painful way of target bacteria.
What do customer use today?
What could be netter with the product used today?
Do they use Mx Ag?
The contamination does usually not affect the wound healing
•All wounds are contaminated.
•One reason for impaired healing may be increasing number of bacteria, critical colonization
• Infected wounds are more painful*
Delphi panel results:
85% of the Delphi panel members agreed that patients with infected chronic wounds suffer more wound pain than those with other chronic wounds.
A Delphi evaluation has been conducted to to investigate if there is a relationship in the chronic wound between pain and and infection and choice of dressings. The Delphi Method is based on a structured process for collecting and distilling knowledge
from a group of experts by means of a series of questionnaires interspersed with controlled opinion feedback. The results from this Delphi panel were clear: infected wounds are more painful than other wounds and dressings have a clear role to play inmanaging this pain.
References:
1. Data on file.
2. White R. A Multinational survey of the assessment of pain when removing dressings. Wounds UK 2008; Vol 4, No 1.
3. White R. Evidence for atraumatic soft silicone wound dressing use. Wounds UK 2005;1(3):104-9.
4. Dykes PJ et al. Effect of adhesive dressings on the stratum corneum of the skin. Journal of Wound Care 2001;10(2):7-10.
5. Meaume S et al. A study to compare a new self adherent soft silicone dressing with a self adherent polymer dressing in stage II pressure ulcers. Ostomy Wound Management 2003;49(9):44ミ51.
6. Wiberg AM et al. Preventing maceration with a soft silicone dressing: in-vitro evaluations. Poster publication. World Union of Wound Healing Societies congress, Toronto, Canada 2008.
7. Taherinejad and Hamberg. Antimicrobial effect of a silver-containing foam dressing on a broad range of common wound pathogens. Poster publication. World Union Congress, Toronto, Canada 2008.
8. External lab report: NAMSA 09C 29253 01/09C 29253 02.
9. Data on file.
10.Silverstein et al. An open, parallel, randomized, comparative, multi-center investigation in the US evaluating the cost-effectiveness, efficacy, safety and tolerance of Mepilexィ Ag versus Silvadeneィ in the treatment of partial thickness burns.
Oral Presentation. The JAB Burn and Wound Care Symposium. Maui, Hawaii, USA, Feb 2010.
11. External lab report: NAMSA 06C 21924 01/06C 21923 01.
12. Data on file.
Ref: EWMA position document : management of wound infection. London: MEP Ltd,2006.
Stage 3-4: possibly local antimicrobial treatment if the wound is open and the wound bed needs therapeutic intervention
Ref: Model modified from Falanga 2003. Suggested treatment: Gray, White et al
This model shows when it is appropriate to use an antimicrobial dressing. This is still theory and not scientifically proved.
The green area represents an increase in bacterial count and the stages in the wound infection continuum. The ‘Yes’ and ‘No’ on the top states if you should use an antimicrobial dressing.
In general, an antimicrobial dressing should not be used in a colonised wound. However, prophylaxis may be considered in vulnerable wound groups such as diabetic foot ulcers, or vulnerable immuno-suppressed patients or if the patient has a recurrent history of infection in this wound.
The optimal solution in this state is a dressing with Safetac.
Critical colonisation: Suggested treatment – antimicrobial dressings suitable for wet wound.
Local infection: Systemic antibiotics – oral + antimicrobial dressings.
Spreading infection: Systemic antibiotics – oral if red zone around the wound is static. Intravenous- if red zone is spreading.
Consider antimicrobial dressing in diabetic foot ulcers, critically ischemic wounds, burns and the severely immuno-compromised patient.
Let me show you why I call this an ingenious product:
First we have a Safetac layer – And now the million dollar question: WHY IS SAFTEC IMPORTANT….?????????????
Wound contact layer so called HSF
Acrylic adhesive
Polyurethane film
Safetac layer
We have a patented foam with silver on top of the Safetac layer. Polyurethane silver foam
It is the same foam as in Mepilex Ag but our R&D group developed it for better spreading of exudate and also for better retention as the foam will be better utilized
And why do we want to spread the exudate?
For one very simple reason: if the exudate is not spread out and to be absorbed into the foam and up and away from the surface but into the superabosorbent pad and then we would perhaps have had problems with silver release. We really want the moist to solve the silver so that it is released into the wound.
It is 1,2 mg silver in the foam as in Mepilex Ag.
The silver compound is silver sulphate and the active part of the silver sulphate e.g. silver is 67% of the total and that makes 1,2 mg/cm2 and that’s why it says 1,2mg/cm2 in the IFU and on the packages.
Mode of action – back up slides for surgeon if needed
Potential wounds for Mepilex Ag Ag
Leg ulcer mixed with signs of high bio burden.
Partial thickness burn where some want to prevent infection and use MxAg on the fresh burn.
May be left in place for 7 days. Note; follow local protocol. When used for prevention for example on burns.
May be left in place for 7 days. Note; follow local protocol. When used for prevention for example on burns.
This one of the first burns that was treated with the Mepilex Ag
The application of Mepilex Ag to the hand. You will see the evolution of finger application after fixation.
A secondary of roll gauze and a tubular fixation dressing
Note: Tubifast can also be used
The appearance of the secondary dressings and the Mepilex Ag
The patient exhibiting their range of motion
Other products may limit the patient’s range of motion which may affect the desired clinical outcome for the patient.
And the appearance of the wound. Notice there is no staining to the wound bed. There is also no damage /to the re-epithielization.
Application of the dressings
The secondary dressings
The appearance of the secondary dressings
The Mepilex Ag
And his healed burn
The outer edges are the remnants of deeper 1st degree burns. This is not staining.
There is no reported staining of the wound bed with Mepilex AG
Appearance of the left hand after the burn. Grey color is staining from oil explosion
Here you see the application to the fingers in a more evolved manner. Note the first two digits have stapled edges and the remaining digits the Mepilex Ag were just folded.
These are the same secondary dressings. You see here the patient has full range of motion.
Here you see the patient demonstrate his range of motion at day 6
The Mepilex Ag does not become stiff and rigid
Healed on the 9:th day.
As you can see very gentle removal from a 4 day old donor site.